Preferential Use of Branched-Chain Amino Acids as an Energy Substrate in Patients with Liver Cirrhosis

We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose, branched-chain amino acids (BCAA) or fatty acids as an energy substrate. Resting energy expenditure (REE), nonprotein respiratory quotient (npRQ),...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 37; no. 5; pp. 429 - 434
Main Authors KATO, Masahiko, MIWA, Yoshiyuki, TAJIKA, Masahiro, HIRAOKA, Tetsuya, MUTO, Yasutoshi, MORIWAKI, Hisataka
Format Journal Article
LanguageEnglish
Published Tokyo The Japanese Society of Internal Medicine 1998
Japanese Society of Internal Medicine
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose, branched-chain amino acids (BCAA) or fatty acids as an energy substrate. Resting energy expenditure (REE), nonprotein respiratory quotient (npRQ), and oxidation rates of glucose (%CHO), protein (%PRO) and fat (%FAT) were analyzed. REE and %FAT were significantly higher and %CHO and %PRO were significantly lower in cirrhosis than in controls. These changes correlated with disease severity. Glucose and BCAA were utilized efficiently as energy substrates and reduced %FAT in cirrhosis. Energy efficacy (increased energy expenditure/energy equivalent of the supplemented nutrient) was significantly higher in BCAA (96±16%) than in glucose (41±8%) (p<0.01) and fatty acids (27±13%) (p<0.05). Patients with cirrhosis have an increased energy requirement. BCAA seems to be the preferred substrate to meet this demand, because its energy efficacy is higher than glucose or fatty acids in cirrhosis. (Internal Medicine 37: 429-434, 1998)
AbstractList We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose, branched-chain amino acids (BCAA) or fatty acids as an energy substrate. Resting energy expenditure (REE), nonprotein respiratory quotient (npRQ), and oxidation rates of glucose (% CHO), protein (% PRO) and fat (% FAT) were analyzed. REE and %FAT were significantly higher and % CHO and %PRO were significantly lower in cirrhosis than in controls. These changes correlated with disease severity. Glucose and BCAA were utilized efficiently as energy substrates and reduced %FAT in cirrhosis. Energy efficacy (increased energy expenditure/energy equivalent of the supplemented nutrient) was significantly higher in BCAA (96 +/- 16%) than in glucose (41 +/- 8%) (p&lt;0.01) and fatty acids (27 +/- 13%) (p&lt;0.05). Patients with cirrhosis have an increased energy requirement. BCAA seems to be the preferred substrate to meet this demand, because its energy efficacy is higher than glucose or fatty acids in cirrhosis.
We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose, branched-chain amino acids (BCAA) or fatty acids as an energy substrate. Resting energy expenditure (REE), nonprotein respiratory quotient (npRQ), and oxidation rates of glucose (%CHO), protein (%PRO) and fat (%FAT) were analyzed. REE and %FAT were significantly higher and %CHO and %PRO were significantly lower in cirrhosis than in controls. These changes correlated with disease severity. Glucose and BCAA were utilized efficiently as energy substrates and reduced %FAT in cirrhosis. Energy efficacy (increased energy expenditure/energy equivalent of the supplemented nutrient) was significantly higher in BCAA (96±16%) than in glucose (41±8%) (p<0.01) and fatty acids (27±13%) (p<0.05). Patients with cirrhosis have an increased energy requirement. BCAA seems to be the preferred substrate to meet this demand, because its energy efficacy is higher than glucose or fatty acids in cirrhosis. (Internal Medicine 37: 429-434, 1998)
We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose, branched-chain amino acids (BCAA) or fatty acids as an energy substrate. Resting energy expenditure (REE), nonprotein respiratory quotient (npRQ), and oxidation rates of glucose (% CHO), protein (% PRO) and fat (% FAT) were analyzed. REE and %FAT were significantly higher and % CHO and %PRO were significantly lower in cirrhosis than in controls. These changes correlated with disease severity. Glucose and BCAA were utilized efficiently as energy substrates and reduced %FAT in cirrhosis. Energy efficacy (increased energy expenditure/energy equivalent of the supplemented nutrient) was significantly higher in BCAA (96 +/- 16%) than in glucose (41 +/- 8%) (p<0.01) and fatty acids (27 +/- 13%) (p<0.05). Patients with cirrhosis have an increased energy requirement. BCAA seems to be the preferred substrate to meet this demand, because its energy efficacy is higher than glucose or fatty acids in cirrhosis.
Author MIWA, Yoshiyuki
HIRAOKA, Tetsuya
KATO, Masahiko
TAJIKA, Masahiro
MUTO, Yasutoshi
MORIWAKI, Hisataka
Author_xml – sequence: 1
  fullname: KATO, Masahiko
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
– sequence: 2
  fullname: MIWA, Yoshiyuki
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
– sequence: 3
  fullname: TAJIKA, Masahiro
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
– sequence: 4
  fullname: HIRAOKA, Tetsuya
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
– sequence: 5
  fullname: MUTO, Yasutoshi
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
– sequence: 6
  fullname: MORIWAKI, Hisataka
  organization: The First Department of Internal Medicine, Gifu University School of Medicine
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1610137$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9652895$$D View this record in MEDLINE/PubMed
BookMark eNplkEFrGzEQhUVJSZ20P6FUh9LbupJWWklH16RJwVBDm7PQSrNZhbU2leSU_PvK2LjQghgd3jdvZt4VuohzBIQ-ULJktNOfQyyQop124IMLEZatXHKmX6EFbbluJGvFBVoQTVXDanmDrnJ-JKRVUrNLdKk7wZQWCzRsEwyQIJZgJ3yfAc8D_pJsdCP4Zj3aEPFqF-KMVy74jG19Ed9ESA8v-Me-zyXZArhSW1tCtcn4dygj3oRnSHgdUhrnHPJb9HqwU4Z3p_8a3X-9-bm-azbfb7-tV5vGCSZKo4QW3neUgOLS-54q1YHgWjGgPSNK9nawnvfaid5xThyxnHeypYN3knvdXqNPR9-nNP_aQy5mF7KDabIR5n02UmtFSUcrKI-gS3PONQPzlMLOphdDiTkkbP5N2LTS1IRr5_vTiH1ftXPfKdKqfzzpNjs7DYcsQ_5rX6-jrazY9og95mIf4KzbVIKb4L_xVGt2WEEcS93kjLrRJgOx_QOr-ajz
CitedBy_id crossref_primary_10_1111_j_1440_1746_2011_07043_x
crossref_primary_10_1097_MEG_0000000000000516
crossref_primary_10_1111_j_1872_034X_2012_00969_x
crossref_primary_10_3892_ijo_2014_2514
crossref_primary_10_1111_j_1872_034X_2008_00391_x
crossref_primary_10_1097_MD_0000000000002442
crossref_primary_10_1111_j_1365_2036_2004_01920_x
crossref_primary_10_3390_nu13020540
crossref_primary_10_1002_elps_201500007
crossref_primary_10_1007_s00535_014_0950_2
crossref_primary_10_1155_2012_859697
crossref_primary_10_1111_hepr_12004
crossref_primary_10_1177_039139880002300606
crossref_primary_10_2460_ajvr_78_6_735
crossref_primary_10_1016_j_bbrc_2003_07_016
crossref_primary_10_1016_S0899_9007_01_00754_7
crossref_primary_10_1097_MD_0000000000003920
crossref_primary_10_1002_mnfr_201200538
crossref_primary_10_1046_j_1440_1681_29_s4_6_x
crossref_primary_10_1007_s40472_019_0223_3
crossref_primary_10_1111_jhn_13076
crossref_primary_10_1016_j_nut_2006_10_008
crossref_primary_10_1016_j_nut_2013_03_017
crossref_primary_10_1016_j_clnu_2020_12_023
crossref_primary_10_1016_j_nut_2013_01_022
crossref_primary_10_4254_wjh_v14_i4_802
crossref_primary_10_1016_j_nut_2014_07_005
crossref_primary_10_1111_hepr_12112
crossref_primary_10_1016_j_nut_2009_04_016
crossref_primary_10_1371_journal_pntd_0003427
crossref_primary_10_1007_s11901_021_00564_y
crossref_primary_10_3390_nu15224770
crossref_primary_10_1111_j_1872_034X_2007_00081_x
crossref_primary_10_1016_j_jhep_2003_11_003
crossref_primary_10_1097_MEG_0000000000001544
crossref_primary_10_1016_j_nut_2009_06_027
crossref_primary_10_3177_jnsv_56_372
crossref_primary_10_1002_lt_21758
crossref_primary_10_3390_nu16121875
crossref_primary_10_1016_j_cld_2011_12_009
ContentType Journal Article
Copyright The Japanese Society of Internal Medicine
1999 INIST-CNRS
Copyright_xml – notice: The Japanese Society of Internal Medicine
– notice: 1999 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.2169/internalmedicine.37.429
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 434
ExternalDocumentID 10_2169_internalmedicine_37_429
9652895
1610137
article_internalmedicine1992_37_5_37_5_429_article_char_en
Genre Journal Article
Comparative Study
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
AAPBV
AAUGY
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
EMOBN
F5P
HYE
JSF
JSH
M48
M~E
OK1
P2P
RJT
RNS
RPM
RZJ
TKC
TR2
X7M
XSB
ADGIM
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PGMZT
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c525t-8595dd610e847ddb1886e54982e1b2087bafad4b9c5bc440c0a446731fdc74d93
ISSN 0918-2918
IngestDate Fri Aug 16 11:24:20 EDT 2024
Fri Aug 23 04:02:25 EDT 2024
Sat Sep 28 08:34:49 EDT 2024
Thu Nov 24 18:30:40 EST 2022
Thu Aug 17 20:27:41 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Energy metabolism
Liver
Nutrition disorder
Hepatic disease
Exploration
Basal metabolism
Branched chain
Cirrhosis
Rest
Clinical stage
Energetic cost
Aminoacid
Digestive diseases
Complication
Malnutrition
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c525t-8595dd610e847ddb1886e54982e1b2087bafad4b9c5bc440c0a446731fdc74d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/internalmedicine1992/37/5/37_5_429/_article/-char/en
PMID 9652895
PQID 79981061
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_79981061
crossref_primary_10_2169_internalmedicine_37_429
pubmed_primary_9652895
pascalfrancis_primary_1610137
jstage_primary_article_internalmedicine1992_37_5_37_5_429_article_char_en
PublicationCentury 1900
PublicationDate 1998-00-00
PublicationDateYYYYMMDD 1998-01-01
PublicationDate_xml – year: 1998
  text: 1998-00-00
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 1998
Publisher The Japanese Society of Internal Medicine
Japanese Society of Internal Medicine
Publisher_xml – name: The Japanese Society of Internal Medicine
– name: Japanese Society of Internal Medicine
References 7) Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 2: 1051, 1967.
6) Yoshida T, Muto Y, Moriwaki H, Yarnato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 24: 692, 1989.
23) O'Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 2: 615, 1980.
39) González J, Periago JL, Gil A, et al. Malnutrition-related polyunsaturated fatty acid changes in plasma lipid fractions of cirrhotic patients. Metabolism 41: 954, 1992.
15) Agarwal NR, Savino JA, Feldman M, Dawson J, Gupte P, Del Guercio LR. The automated metabolic profile. Crit Care Med 11: 546, 1983.
18) Shanbhogue RL, Bistrian BR, Jenkins RL, Jones C, Benotti P, Blackburn GL. Resting energy expenditure in patients with end-stage liver disease and in normal populations. JPEN J Parenteral Enteral Nutr 11: 305, 1987 (see comments).
27) Müller MJ, Böker KH, Selberg O. Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin Investig 72: 568, 1994.
36) Ichihara A, Koyama E. Transaminase for branched chain amino acids. I. Branched chain amino acids-α-ketoglutarate transaminase. J Biochem (Tokyo) 59: 160, 1966.
12) Konstantinides FN, Boehm KA, Radmer WJ, et al. Pyrochemiluminescence: Real time, cost-effective method for determining total urinary nitrogen in clinical nitrogen-balance studies. Clin Chem 34:2518, 1988.
24) Eriksson LS. Branched-chain amino acids in the treatment of hepatic encephalopathy. in: Hepatic Encephalopathy: Management with Lactulose and Related Carbohydrates. Conn HO, Bircher J, Eds. Medi-Ed Press, East Lansing, 1988, p. 129.
31) Müller MJ. Hepatic fuel selection. Proc Nutr Soc 54: 139, 1995.
34) Hayashida Y, Kido Y, Tsujinaka T, et al. Increased energy expenditure after intravenous administration of amino acids. JPEN J Parenteral Enteral Nutr 16: 142, 1992.
40) Cabré E, Abad-Lacruz A, Núñez MC, et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am J Gastroenterol 88: 718, 1993.
4) Swart GR, van den Berg JWO, van Vuure JK, Rietveld T, Wattimena DL, Freukel M. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 8: 329, 1989.
41) Samson FE Jr, Dahl N, Dahl DR. A study on the narcotic action of the short chain fatty acids. J Clin Invest 35: 1291, 1956.
43) Muto Y. Clinical study on the relationship of short-chain fatty acids and hepatic encephalopathy. Jpn J Gastroenterol 63: 19, 1966.
16) Owen OE, Trapp VE, Reichard GA Jr, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 72: 1821, 1983.
21) Heymsfield SB, Waki M, Reinus J. Are patients with chronic liver disease hypermetabolic? Hepatology 11: 502, 1990.
30) Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ. Identification of high- or low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25: 652, 1997.
25) O'Keefe SJD. Parenteral nutrition and liver disease, in: Clinical Nutrition-Parenteral Nutrition. Rombeau JL, Caldwell MD, Eds. W.B. Saunders, Philadelphia, 1993, p. 676.
14) Harris JA, Benedict EG. A Biometric Study of Basal Metabolism in Man. Carnegie Institute of Washington, Washington DC, 1919; no. 297.
29) Müller MJ, Loyal S, Schwarze M, et al. Resting energy expenditure and nutritional state in patients with liver cirrhosis before and 432 days after liver transplantation. Clin Nutr 13: 145, 1994.
37) Kato M, Yoshida Y, Moriwaki H, Muto Y. Effect of branched-chain amino acid (BC AA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients. Acta Hepatol Jpn 25: 692, 1991 (in Japanese).
8) ZieveZ. The mechanism of hepatic coma. Hepatology 1: 360, 1981.
17) Jhangiani SS, Agarwal N, Holmes R, Cay ten CG, Pitchumoni CS. Energy expenditure in chronic alcoholics with and without liver disease. Am J Clin Nutr 44: 323, 1986.
33) Kruszynska YT, Home PD, Mclntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14: 103, 1991.
28) Müller MJ, Lauts HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 15: 782, 1992.
38) Usui T, Moriwaki H, Hatakeyama H, et al. Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J Nutr 126: 1412, 1996.
9) Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80: 77, 1976.
5) Chalasani N, Gitlin N. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am J Gastroenterol 91: 1266, 1996.
26) Campillo B, Bories PN, Pornin B, Devanley M. Influence of liver failure, ascites and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 13: 613, 1997.
3) Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain,amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 2: 420, 1982.
13) Takala J, Merilainen P. Handbook of Gas Exchange and Indirect Calorimetry. Datex Division Instrumentarium Corp., Helsinki, 1987.
11) Lunderquist A, Simert G, Tylén U, Vang J. Follow-up of patients with portal hypertension and esophageal varices treated with percutaneous obliteration of gastric coronary vein. Diagn Radiology 122: 59, 1977.
10) Miwa Y, Kato M, Moriwaki H, et al. Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure. Hepatology 22: 291, 1995.
19) Müller MJ, Fenk A, Lautz HU, et al. Energy expenditure and substrate metabolism in ethanol-induced liver cirrhosis. Am J Physiol 260: E338, 1991.
32) Johnson DG, Alberti KG, Faber OK, Binder C. Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion. Lancet 1: 10, 1977.
20) Schneeweiss B, Graninger W, Ferenci P, et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology 11: 387, 1990.
42) Muto Y, Takahashi Y, Kawamura H. Effect of short-chain fatty acids on the electrical activity of neo-, paleo-, and archicortical system. Brain Nerve 16: 601, 1964.
1) Morgan AG, Kelleher J, Walker BE, Losowsky MS. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 17: 113, 1976.
2) Freund H, Yoshimura N, Lunetta L, Fischer JE. The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery 83: 611, 1978.
22) Crawford DH, Shepherd RW, Halliday JW, et al. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology 106: 1611, 1994.
35) Munro HN, Fernstrom JD, Wurtman RJ. Insulin, plasma amino acid imbalance, and hepatic coma. Lancet 1: 722, 1975.
References_xml
SSID ssj0038792
Score 1.7612181
Snippet We analyzed basal energy metabolism in 20 healthy volunteers and 41 cirrhotic patients by indirect calorimetry. Subjects were then given either glucose,...
SourceID proquest
crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 429
SubjectTerms Amino Acids, Branched-Chain - administration & dosage
Amino Acids, Branched-Chain - metabolism
Biological and medical sciences
Blood Urea Nitrogen
Calorimetry, Indirect
Creatinine - metabolism
energy efficacy
Energy Metabolism
Fatty Acids - administration & dosage
Fatty Acids - metabolism
Female
Gastroenterology. Liver. Pancreas. Abdomen
Glucose - administration & dosage
Glucose - metabolism
Humans
indirect calorimetry
Liver Cirrhosis - metabolism
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Nitrogen - urine
Other diseases. Semiology
protein-energy malnutrition
Severity of Illness Index
Urea - metabolism
Title Preferential Use of Branched-Chain Amino Acids as an Energy Substrate in Patients with Liver Cirrhosis
URI https://www.jstage.jst.go.jp/article/internalmedicine1992/37/5/37_5_429/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/9652895
https://search.proquest.com/docview/79981061
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 1998, Vol.37(5), pp.429-434
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELbKgtBKCHGtKLDgB96qlBx2jscIgTZblUUoK_YtSmxHDSzNqmkflr_En2QmdtK0sOKQqqiy4hyeb87MjAl57UgpVBCUlvJ9bjGR-1bueREwXsSAt7gqfCxOnn_wT87Z6QW_GI1-DLKWNutiKr7_tq7kf6gKY0BXrJL9B8r2F4UB-A_0hSNQGI5_ReOPZpOQNYa9NzoqX-BOGQslLbEAp3-Sf6uW9SQXlWxwSxngZqWr_RqQGG1n2sm2u6opdbvEXI2JqFarRd1UzdB-NQHEy_6bPFqoaf31uo24YpLpILQwi9OznYDrPPkcb2U-xgvi02QW7wZlk0_xmR5LtyEJrNHbKgpQ8LhxZp9yasph2gebD5MFTAzSwRIQI4CVlsAei6zA1T1MOhGt-8IYKPKBvGXmnbTqZjouuq8VXMfHpqqVeZBugaZeMO3nD_tw7-nHPmsRjGNs0HiL3HYDcCvRAk9mndr3AN3tJ6vunXQyId77zQ133jGF7nwBbwDbPNy7yhtgz1Lvq3Kz49MaQOkDct94LjTWMHxIRmr5iNztlvsxKYdopIBGWpd0F420RSNt0Uhz-C2pRiPt0UjhrA6NFNFIWzTSHo1PyPn7d-nbE8vs4mEJ7vK1hQ30pISlU2AISVk4YegrzqLQVU7h2mFQ5GUuWREJXgjGbGHnDLS355RSBExG3hE5WNZL9ZRQNDhhwHYEGP7geYDvEipb-Exh1zrfGRO7W9DsSjdrycDJRRpk-zTIvCADGoxJohe-n2C4-ZcJyEI4iesDzO1PxQJJkEdjcrxDu-0zaOCMyauOlhkIcfwyB9xSb5osACbC2MyYHGkS91Mjn7thxJ_94dLPyaEulsXY4AtysF5t1DFYy-viZYvSn4AVxeo
link.rule.ids 315,786,790,4043,27956,27957,27958
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preferential+use+of+branched-chain+amino+acids+as+an+energy+substrate+in+patients+with+liver+cirrhosis&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=KATO%2C+M&rft.au=MIWA%2C+Y&rft.au=TAJIKA%2C+M&rft.au=HIRAOKA%2C+T&rft.date=1998&rft.pub=Japanese+Society+of+Internal+Medicine&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=37&rft.issue=5&rft.spage=429&rft.epage=434&rft_id=info:doi/10.2169%2Finternalmedicine.37.429&rft.externalDBID=n%2Fa&rft.externalDocID=1610137
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon